Programme: SCORM Example
Programme: SCORM Example
Joanne Pearson, Prof. Dr. Ángel Cequier Fillat, Prof. Dr. Uwe Zeymer, Prof. Dr. Gilles Montalescot, Prof. Dr. Zuzana Motovska
In this micro e-learning you will learn about the potential existence of von Willebrand disease, be able to recognise the signs and symptoms, understand how you can help diagnose and care for a patient with VWD. Watch the short video, download the flashcard and slides, and take the assessment to check your knowledge.
Joanne Pearson
Gynaecologic Oncology
University Hospital Southampton NHS Foundation Trust
United Kingdom (UK)
Prof. Dr. Ángel Cequier Fillat
Cardiologist
University of Barcelona
Spain
Prof. Dr. Uwe Zeymer
Cardiologist
Heart Center Ludwigshafen
Germany
Prof. Dr. Gilles Montalescot
Cardiologist
Pitié-Salpêtrière Hospital
France
Prof. Dr. Zuzana Motovska
Cardiologist
Charles University
Czech Republic
Joanne Pearson
Gynaecologic Oncology
University Hospital Southampton NHS Foundation Trust
United Kingdom (UK)
Jo Pearson, RN has been a cancer nurse for over 15 years, beginning her career in SACTadministration in a busy cancer centre before developing an interest in supporting women whohave a gynaecologicalcancer diagnosis. Jo became a Macmillan Gynae/Oncology Clinical NurseSpecialist (CNS) 6 years ago and enjoys supporting women and their families from pre-diagnosisthrough their treatment pathways.Jo has a special interest in cancer genomics having recently completed a course with Guy’s andSt Thomas’,and has established a weekly BRCA consenting and holistic needs clinic. Jo haspresented at national and international forums and has contributed to several publications inrelation to nurse-led PARP clinics and other service development initiatives. Jo is a mother of 2who enjoys live music and travelling.
Joanne Pearson has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Prof. Dr. Ángel Cequier Fillat
Cardiologist
University of Barcelona
Spain
-Professor of Cardiology. University of Barcelona. -Senior Teacher. Division of Cardiology. Bellvitge University Hospital -President of the Spanish Society of Cardiology -Director Heart Disease Institute, Bellvitge University Hospital (2010-2019) -Head of the Cardiovascular Group Research. IDIBELL (Bellvitge Research Institute). Barcelona (2010-2019). -President Scientific Committee AMI Code in Catalonia (2014-2018). -Director of the International Course “Prevention and Treatment of Complications in Percutaneous Interventional Cardiology". -Barcelona 2004, 2006, 2008, 2010, 2012, 2014, 2016 and 2018. Education and training in Cardiology: -Graduate in Medicine (University of Barcelona) -Residence in Cardiology (Bellvitge University Hospital) -PhD (University of Barcelona - 1994) -MCCEFG: Medical Council of Canada. Ottawa. Canada. (1987) -ECFMG: Educational Commission for Foreign Medical Graduates. Philadelphia, Pennsylvania. USA (1987) -Clinical and Research Fellowship in Interventional Cardiology: Montreal Heart Institute. University of Montreal. Canada (1986-1988). Scientific and Research Activity: - Three hundred articles published in International and National Journals (New England Journal of Medicine, Lancet, Circulation, European Heart Journal, Journal American College of Cardiology, Revista Española de Cardiologia, etc - Twenty books or book chapters. - 8 directed Doctoral Theses, - 97 research projects, PI and National Coordinator in multiple clinical trials.
Prof. Dr. Ángel Cequier Fillat has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Prof. Dr. Uwe Zeymer
Cardiologist
Heart Center Ludwigshafen
Germany
Prof. Dr. Uwe Zeymer is Head of Interventional Cardiology at the Heart Center Ludwigshafen, Department of Cardiology, Germany. He is Vice-Director of the Institut für Herzinfarktforschung Ludwigshafen. He has been board certified in internal medicine, cardiology, interventional cardiology and intensive care medicine. After his graduation from Medical School at the Universities of Munich and Marburg in 1985, Dr Zeymer gained experience as a resident, fellow and attendee in the Department of Cardiology, Municipal Hospital, Kassel, and as a clinical research fellow in the Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, USA. He is full Professor of Medicine at the University of Göttingen. Dr. Zeymer is or has chaired or been a member of the Steering Committee numerous trials in patients with acute coronary syndromes, antithrombotic therapies and anticoagulants. In addition, he has been chair or member of the Steering committee of several international registries in interventional cardiology, treatment of hypertension, anticoagulation for atrial fibrillation and acute coronary syndromes. Dr. Zeymer has authored and co-authored over 450 scientific papers on cardiovascular disease in journals such as the New England Journal of Medicine, Lancet, JAMA, European Heart Journal, Circulation and Journal of the American College of Cardiology. Dr. Zeymer has been the Chair of the Scientific Committee of the Acute Cardiovascular Care Association of the ESC, the Chair of the Working Group of Thrombosis of the German Cardiac Society and the Chair of the Working for Quality Insurance and Registries of the German Cardiac Society. He was President of the annual Autumn Meeting of the German Cardiac Society 2013. He is currently chairing the ongoing STEMI-Registry of the EORP of the ESC.
Prof. Dr. Uwe Zeymer has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Prof. Dr. Gilles Montalescot
Cardiologist
Pitié-Salpêtrière Hospital
France
Gilles Montalescot is Professor of Cardiology at the Pitié Salpêtrière Hospital in Paris, France, where he heads the Department of Cardiology at the Institute of Cardiology. He is a practicing Interventional Cardiologist and has extensive experience in basic and clinical research. He has been the director of the INSERM research Unit UMRS_1166 on Thrombosis for 10 years. Dr Montalescot has been an investigator for many of the new drugs developed in the past twenty years as well as for many of the new interventional technologies. Dr. Montalescot is a senior scientist and has been the lead investigator of many national or international randomized trials including ADMIRAL, ARMADA, ALBION, STEEPLE, ARCHIPELAGO, ABOARD, ACAPULCO, ATOLL, ARCTIC, ANTARCTIC, ACCOAST, ATLANTIC, AEGEAN, AMERICA, ALBATROS, and the ongoing ATLANTIS, ALPHEUS, ARAMIS, ADRIFT trials. Dr Montalescot is the Chairman of the ACTION study group, an Academic Research Organization based at Pitié Salpêtrière Hospital in Paris. He has served on several task force committees on antithrombotic drugs and acute coronary syndromes and is the current Chairman of the Stable Coronary Artery disease guidelines of the European Society of Cardiology. Dr Montalescot has received several awards in his country including the J. Valade Prize from the Fondation de France and the J.Escalle award from the National Academy of Medicine. He is a member of several editorial boards and has published over 600 peer reviewed original articles in journals such as the NEJM, JAMA, Lancet. Internationally, Dr. Montalescot has also been an invited speaker at plenary sessions of major congresses such as the European Society of Cardiology, the American College of Cardiology ,and the American Heart Association.
Prof. Dr. Gilles Montalescot has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Prof. Dr. Zuzana Motovska
Cardiologist
Charles University
Czech Republic
Present Position and Address Head of the Division of Acute Cardiology Deputy Head of Department for the Research Cardiology Department Cardiocenter Third Faculty of Medicine, Charles University University Hospital Kralovské Vinohrady Prague, Czech Republic Post Graduate Degrees Appointed as Professor of Internal Medicine at the Charles University, Prague, Czech Republic European Society of Cardiology Activities Councilor of the ESC Board 2018-2020 Member of Working group on Thrombosis Member of Acute Cardiovascular Care Association National coordinator of the ACS-STEMI Registry EORP Fellowships / Honours Fellow of European Society of Cardiology (since 2007) Award given by the Ministry of Education, Youth and Sports of Czech Republic for extraordinary results in research, experimental development and innovation – awarded in the year 2015 Major Research Interest Acute coronary syndromes Acute cardiac care Antithrombotic therapy Cardiovascular disease in women Cardiogenic shock Major Scientific Activities Principal investigator (design, leadership, coordination): Multicenter randomized PRAGUE 8 study Multicenter randomized PRAGUE 18 study Multicenter double-blind randomized DAPT-SCHOCK-AMI (PRAGUE 23) study (ongoing)
Prof. Dr. Zuzana Motovska has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
SCORM Example
| 60 min |accreditation: EACCME | Mar 2023
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
This micro e-learning programme consists of three modules aiming to increase awareness, knowledge and understanding of the existence, diagnosis, treatment and implications of von Willebrand disease among healthcare professionals outside of haematology.
Upon completion of the three modules, you will:
-
be aware of the potential existence of von Willebrand disease in your patient population
-
be able to recognise the signs and symptoms of von Willebrand disease
-
understand how to search for von Willebrand disease, effectively using the screening tools available and signposting patients towards earlier diagnosis
-
be aware of the impact of von Willebrand disease on other care
This micro e-learning is endorsed by:
This educational programme is supported by an Independent Medical Education Grant from Ultragenyx, PharmaMar, Novonordisk, Pfizer.
HEMOSTASIS CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Takeda.
Other programmes of interest
Other programmes developed by Joanne Pearson
Joanne Pearson
Gynaecologic Oncology
University Hospital Southampton NHS Foundation Trust
United Kingdom (UK)